Raymond Cross Jr, MD, from the University of Maryland, is a cochair of the Advances in Inflammatory Bowel Diseases Regional Meeting in Baltimore, Maryland. In this podcast, he provides highlights of the upcoming meeting and explains key concepts for clinicians to implement into practice.

In this podcast, Andrew Admon, MD, MPH, discusses his latest research that assessed whether the Medicaid expansion in some states affected mechanical ventilation rates among hospitalized patients with heart failure, asthma, and chronic obstructive pulmonary disease (COPD). More at: www.consultant360.com/pulmonology.

In this podcast, Benjamin Freed, MD, talks about what speckle tracking echo is, how to use it to manage pulmonary hypertension, and the challenges associated with its use. More at: www.consultant360.com/pulmonology.

In this podcast, Joseph Bocchini Jr, MD, discusses a new study on adolescent vaccination data published by the Centers for Disease Control and Prevention. Are adolescents receiving the adequate vaccinations? Listen in to find out! More at: www.consultant360.com/infectious-diseases.

In this podcast, Andrew Limper, MD, discusses his latest research on 2 antifibrotic drugs for the treatment of idiopathic pulmonary fibrosis, which was recently published by the American Thoracic Society. More at: www.consultant360.com/pulmonology.

In this podcast, Babak Mokhlesi, MD, discusses the recent guideline for evaluating and treating obesity hypoventilation syndrome, which was published by the American Thoracic Society. More at: www.consultant360.com/pulmonology.

In this podcast, William Schaffner, MD, discusses the new recommendations for pneumococcal vaccination put forth by the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices. More at: www.consultant360.com/infectious-diseases.

In this podcast, Spyridon Fortis, MD, talks about his research on how bronchodilator response in both forced expiratory volume in 1 second and forced vital capacity may indicate COPD-asthma overlap. More at: www.consultant360.com/pulmonology.

Philip J. Mease, MD, from Swedish Medical Center, discusses results from a phase 2 clinical trial on tildrakizumab—an anti-interleukin-23p19 monoclonal antibody—and its potential as a therapeutic option for psoriatic arthritis.

In this podcast, Sonali Thosani, MD, from The University of Texas MD Anderson Cancer Center, discusses the management of bone health among long-term cancer survivors, the importance of osteoporosis screening, and more.